Share on StockTwits
 

Thermo Fisher Scientific (NYSE:TMO) SVP Thomas W. Loewald sold 22,437 shares of the company’s stock in a transaction that occurred on Thursday, February 6th. The stock was sold at an average price of $114.24, for a total value of $2,563,202.88. Following the sale, the senior vice president now directly owns 40,483 shares in the company, valued at approximately $4,624,778. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link.

A number of research firms have recently commented on TMO. Analysts at Zacks reiterated a “neutral” rating on shares of Thermo Fisher Scientific in a research note to investors on Tuesday. They now have a $121.00 price target on the stock. Separately, analysts at Leerink Swann raised their price target on shares of Thermo Fisher Scientific from $107.00 to $130.00 in a research note to investors on Friday, January 31st. They now have an “outperform” rating on the stock. Finally, analysts at Cantor Fitzgerald raised their price target on shares of Thermo Fisher Scientific from $128.00 to $136.00 in a research note to investors on Friday, January 31st. Four equities research analysts have rated the stock with a hold rating and ten have assigned a buy rating to the company. Thermo Fisher Scientific has an average rating of “Buy” and an average target price of $110.93.

Shares of Thermo Fisher Scientific (NYSE:TMO) traded up 2.92% during mid-day trading on Friday, hitting $117.77. The stock had a trading volume of 3,180,691 shares. Thermo Fisher Scientific has a one year low of $71.60 and a one year high of $117.68. The stock’s 50-day moving average is $112.4 and its 200-day moving average is $99.05. The company has a market cap of $42.609 billion and a P/E ratio of 32.84.

Thermo Fisher Scientific (NYSE:TMO) last posted its quarterly earnings results on Friday, January 31st. The company reported $1.43 earnings per share for the quarter, beating the analysts’ consensus estimate of $1.38 by $0.05. The company had revenue of $3.47 billion for the quarter, compared to the consensus estimate of $3.31 billion. Analysts expect that Thermo Fisher Scientific will post $6.80 EPS for the current fiscal year.

Thermo Fisher Scientific Inc (NYSE:TMO) is engaged in serving science.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.